日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.

BVAC-C 治疗 HPV 16 型或 18 型阳性宫颈癌且一线铂类化疗失败患者的疗效和安全性:一项 I/IIa 期研究

Choi Chel Hun, Lee Jeong-Won, Bae Duk-Soo, Kang Eun-Suk, Cho Duck, Kim Yong-Man, Kim Kidong, Kim Jae-Weon, Kim Hee Seung, Kim Young-Tae, Lee Jung-Yun, Lim Myong Cheol, Oh Taegwon, Song Boyeong, Jeon Insu, Park Myunghwan, Kim Wu Hyun, Kang Chang-Yuil, Kim Byoung-Gie

First-in-Human Phase 1 Study of a B Cell- and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer

针对HER2阳性晚期胃癌的基于B细胞和单核细胞的免疫治疗疫苗的首次人体I期研究

Jung, Minkyu; Lee, Jii Bum; Kim, Hyo Song; Kwon, Woo Sun; Kim, Hyun Ok; Kim, Sinyoung; Park, Myunghwan; Kim, Wuhyun; Choi, Ki-Young; Oh, Taegwon; Kang, Chang-Yuil; Chung, Hyun Cheol; Rha, Sun Young

The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates

表达工程化刺突蛋白的嵌合腺病毒(Ad5/35)可使小鼠和非人灵长类动物获得针对SARS-CoV-2的免疫力

Shin, Seung-Phil; Shin, Kwang-Soo; Lee, Jeong-Mi; Jung, In-Kyung; Koo, Jimo; Lee, Seung-Woo; Park, Seowoo; Shin, Jieun; Park, Myunghwan; Park, Bongju; Oh, Hanseul; Koo, Bon-Sang; Hong, Jungjoo; Ryu, Choong-Min; Kim, Jae-Ouk; Oh, Taegwon; Kang, Chang-Yuil

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer

一项针对人乳头瘤病毒16型或18型阳性复发性宫颈癌的基于B细胞和单核细胞的免疫治疗疫苗BVAC-C的I期研究

Choi, Chel Hun; Choi, Hyun Jin; Lee, Jeong-Won; Kang, Eun-Suk; Cho, Duck; Park, Byung Kwan; Kim, Yong-Man; Kim, Dae-Yeon; Seo, Hyungseok; Park, Myunghwan; Kim, Wuhyun; Choi, Ki-Young; Oh, Taegwon; Kang, Chang-Yuil; Kim, Byoung-Gie